KURA
Kura Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.26
−2.84%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 5.32x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 18.85x
- Price / sales
- 11.82x
- Price / cash flow
- -8.17x
Enterprise value
- Enterprise value
- $418.2M
- EV / sales
- 5.41x
- EV / EBITDA
- -1.42x
- EV / EBIT
- -1.31x
- Market cap
- $912.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026